Published in:
Open Access 01-12-2018 | Correction
Correction to: The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan
Published in: Diabetology & Metabolic Syndrome | Issue 1/2018
Login to get accessExcerpt
It has been highlighted that the original article [1], published 21 February 2018, contained some errors in Table 3. This correction article shows the correct version of Table 3 and the changes that were made.
Table 3
The prevalence of peripheral neuropathy among patients with type 2 diabetes mellitus in Jordan according to relevant socio-demographic, clinical and laboratory characteristics
|
Variables
|
Peripheral neuropathy
|
P value
|
|
|---|---|---|---|
|
Yes
n = 396
|
No
n = 607
|
||
|
Gender
|
0.137
|
||
|
Male
|
201 (41.9)
|
279 (58.1)
|
|
|
Female
|
195 (37.3)
|
328 (62.7)
|
|
|
Age (year)
|
< 0.001
|
||
|
< 50
|
23 (17.4)
|
109 (82.6)
|
|
|
50–69
|
269 (38.9)
|
423 (61.1)
|
|
|
≥ 70
|
104 (58.1)
|
75 (41.9)
|
|
|
Marital status
|
0.777
|
||
|
Single/divorced/widowed
|
52 (40.6)
|
76 (59.4)
|
|
|
Married
|
344 (39.3)
|
531 (60.7)
|
|
|
Working status
|
< 0.001
|
||
|
Unemployed
|
175 (50.9)
|
169 (49.1)
|
|
|
Employed
|
83 (29.6)
|
197 (70.4)
|
|
|
Retired
|
138 (36.4)
|
241 (63.6)
|
|
|
Physical activity
|
< 0.001
|
||
|
Regular
|
29 (31.5)
|
63 (68.5)
|
|
|
Not regular
|
72 (25)
|
216 (75)
|
|
|
No physical activity
|
295 (47.4)
|
328 (52.6)
|
|
|
Family history of diabetes
|
0.014
|
||
|
Present
|
356 (41)
|
513(59)
|
|
|
Absent
|
40 (29.9)
|
94 (70.1)
|
|
|
Regular visit to treating physicians
|
< 0.001
|
||
|
Yes
|
342 (37.3)
|
575 (62.7)
|
|
|
No
|
54 (62.8)
|
32 (37.2)
|
|
|
Body mass index (kg/m2)
|
0.052
|
||
|
Normal
|
32 (37.6)
|
53 (62.4)
|
|
|
Over weight
|
103 (34.1)
|
199 (65.9)
|
|
|
Obese
|
261 (42.4)
|
355 (57.6)
|
|
|
Duration of diabetes (year)
|
< 0.001
|
||
|
< 5
|
29 (8.7)
|
304 (91.3)
|
|
|
5–11
|
139 (39)
|
217 (61)
|
|
|
≥ 12
|
288 (72.6)
|
86 (27.4)
|
|
|
Having hypertension
|
< 0.001
|
||
|
Yes
|
374 (43.5)
|
486 (56.5)
|
|
|
No
|
22 (15.4)
|
121 (84.6)
|
|
|
Nephropathy
|
< 0.001
|
||
|
Yes
|
65 (69.1)
|
29 (30.9)
|
|
|
No
|
331 (36.4)
|
578 (63.6)
|
|
|
Cardiovascular disease
|
< 0.001
|
||
|
Yes
|
210 (54.8)
|
173 (45.2)
|
|
|
No
|
186 (30)
|
434 (70)
|
|
|
Dyslipidemia
|
< 0.001
|
||
|
Yes
|
381 (43)
|
505 (57)
|
|
|
No
|
15 (12.8)
|
102 (87.2)
|
|
|
Retinopathy
|
< 0.001
|
||
|
Yes
|
132 (67.3)
|
64 (32.7)
|
|
|
No
|
264 (32.7)
|
543 (67.3)
|
|
|
Type of treatment
|
< 0.001
|
||
|
Insulin only
|
77 (60.2)
|
51 (39.8)
|
|
|
Oral hypoglycemia agents only
|
120 (22.8)
|
407 (77.2)
|
|
|
Oral hypoglycemia agents and insulin
|
199 (57.2)
|
149 (42.8)
|
|
|
HbA1c (%)
|
< 0.001
|
||
|
Controlled < 7%
|
96 (22.7)
|
326 (77.3)
|
|
|
Uncontrolled ≥ 7%
|
300 (51.6)
|
281 (48.4)
|
|